Arch Venture Fund Vii, L.P. sold $1.1M of Syros Pharmaceuticals, Inc.

10% owner

Sold$1,118,649

$6.80Price

164,583Shares

−4%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Thu, Mar 7. Filed Mon, Mar 11, 1:58 PM ET, during the session. Not investment advice.